FDA Offers Incentive For Prompt Responses To Inspections
This article was originally published in The Tan Sheet
Executive Summary
FDA's new enforcement strategy allows firms possibly to mitigate the severity of warning letters as an incentive for responding to inspection reports
You may also be interested in...
Office Of Regulatory Affairs Faces Training Challenges
Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers
Office Of Regulatory Affairs Faces Training Challenges
Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers
Office Of Regulatory Affairs Faces Training Challenges
Better funding for enforcement brings FDA's Office of Regulatory Affairs new challenges, including training an influx of investigators and adjusting to the retirement of more experienced staffers